Back to BMRN
VIKING GLOBAL INVESTORS LP → BMRN
VIKING GLOBAL INVESTORS LP BMRN Position History
BioMarin Pharmaceutical Inc. • Healthcare
Quarters held
14
Latest value
$435.8M
Q2 2026
Peak value
$763.5M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $210.9M |
| Q2 2023 | $360.3M |
| Q3 2023 | $373M |
| Q4 2023 | $471.4M |
| Q1 2024 | $560.4M |
| Q2 2024 | $581.5M |
| Q3 2024 | $685.6M |
| Q4 2024 | $690.9M |
| Q1 2025 | $763.5M |
| Q2 2025 | $675.5M |
| Q3 2025 | $450.7M |
| Q4 2025 | $358.8M |
| Q1 2026 | $398.9M |
| Q2 2026 | $435.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $435.8M | 7.62M | — | — |
| Q1 2026 | $398.9M | 7.06M | — | — |
| Q4 2025 | $358.8M | 6.04M | — | — |
| Q3 2025 | $450.7M | 8.32M | — | — |
| Q2 2025 | $675.5M | 12.29M | — | — |
| Q1 2025 | $763.5M | 10.80M | — | — |
| Q4 2024 | $690.9M | 10.51M | — | — |
| Q3 2024 | $685.6M | 9.75M | — | — |
| Q2 2024 | $581.5M | 7.06M | — | — |
| Q1 2024 | $560.4M | 6.42M | — | — |
| Q4 2023 | $471.4M | 4.89M | — | — |
| Q3 2023 | $373M | 4.22M | — | — |
| Q2 2023 | $360.3M | 4.16M | — | — |
| Q1 2023 | $210.9M | 2.17M | — | — |
Other funds holding BMRN
$1.4B
$1.3B
$1.3B
$1.3B
$1.3B
$1.2B
$1.2B
$1.1B